- Home
- RFI vs CYRX Comparison
RFI vs CYRX Comparison
Compare RFI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFI
- CYRX
- Stock Information
- Founded
- RFI 1992
- CYRX 1999
- Country
- RFI United States
- CYRX United States
- Employees
- RFI N/A
- CYRX N/A
- Industry
- RFI Investment Managers
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- RFI Finance
- CYRX Health Care
- Exchange
- RFI Nasdaq
- CYRX Nasdaq
- Market Cap
- RFI 323.2M
- CYRX 328.9M
- IPO Year
- RFI N/A
- CYRX N/A
- Fundamental
- Price
- RFI $12.17
- CYRX $7.49
- Analyst Decision
- RFI
- CYRX Strong Buy
- Analyst Count
- RFI 0
- CYRX 8
- Target Price
- RFI N/A
- CYRX $10.75
- AVG Volume (30 Days)
- RFI 69.8K
- CYRX 583.2K
- Earning Date
- RFI 01-01-0001
- CYRX 08-05-2025
- Dividend Yield
- RFI 8.25%
- CYRX N/A
- EPS Growth
- RFI N/A
- CYRX N/A
- EPS
- RFI N/A
- CYRX N/A
- Revenue
- RFI N/A
- CYRX $232,134,000.00
- Revenue This Year
- RFI N/A
- CYRX N/A
- Revenue Next Year
- RFI N/A
- CYRX $9.63
- P/E Ratio
- RFI N/A
- CYRX N/A
- Revenue Growth
- RFI N/A
- CYRX 11.75
- 52 Week Low
- RFI $9.62
- CYRX $4.58
- 52 Week High
- RFI $12.52
- CYRX $9.78
- Technical
- Relative Strength Index (RSI)
- RFI 56.65
- CYRX 61.17
- Support Level
- RFI $11.75
- CYRX $6.16
- Resistance Level
- RFI $12.18
- CYRX $7.96
- Average True Range (ATR)
- RFI 0.15
- CYRX 0.45
- MACD
- RFI 0.02
- CYRX 0.05
- Stochastic Oscillator
- RFI 88.37
- CYRX 71.11
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.